R. Azziz

Reproductive Medicine · 2001–2018

A researcher in the Science corpus: 12 papers; trusts 1 researcher and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Reproductive Medicine — 45 citations into it; #49 of 208 by trust here, #5 by citations

Whom R. Azziz trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. J. Seckl
2. E. Ford
3. Bart C. J. M. Fauser

Who trusts R. Azziz overall

1. Bart C. J. M. Fauser
2. R. Legro
3. H. Escobar-Morreale
4. E. Diamanti-Kandarakis
5. R. Rosenfield
6. D. Ehrmann
7. Siew S. Lim
8. Didier Dewailly
9. D. Dumesic
10. R. Norman

Papers from R. Azziz's perspective

Ordered by how strongly the researchers R. Azziz trusts endorse each paper. Same corpus, a different order for every researcher.

1. Polycystic ovary syndrome (Nature Reviews Disease Primers)
2. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. (European Journal of Endocrinology)
3. AGREE II: advancing guideline development, reporting and evaluation in health care (Canadian Medical Association Journal)
4. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
5. Ultrasound assessment of the polycystic ovary: international consensus definitions. (Human Reproduction Update)
6. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (Journal of Clinical Endocrinology and Metabolism)
7. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (Journal of Clinical Endocrinology and Metabolism)
8. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. (Journal of Clinical Endocrinology and Metabolism)
9. Diagnosis and complications of Cushing's syndrome: a consensus statement. (Journal of Clinical Endocrinology and Metabolism)
10. The metabolic syndrome: time for a critical appraisal (Diabetologia)

Their papers

• Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018) — 2,461 citations
• Criteria, prevalence, and phenotypes of polycystic ovary syndrome. (2016) — 1,131 citations
• Polycystic ovary syndrome (2016) — 4,774 citations
• Polycystic ovary syndrome: etiology, pathogenesis and diagnosis (2011) — 1,387 citations
• Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. (2010) — 1,292 citations
• The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009) — 2,022 citations
• Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. (2007) — 1,184 citations
• Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006) — 1,909 citations
• Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. (2006) — 699 citations
• Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. (2005) — 605 citations
• Androgen excess in women: experience with over 1000 consecutive patients. (2004) — 887 citations
• Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. (2001) — 594 citations